A study to assess safety, tolerability, and pharmacokinetics of AZD0186

Trial Identifier:	D8740C00001
Sponsor:	AstraZeneca
Collaborator:	Parexel
NCTID::	NCT05694741
Start Date:	December 2022
Primary Completion Date:	May 2023
Study Completion Date:	May 2023
Condition:	Diabetes: Type 2

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description
	English Version

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
US, CA	Glendale, CA, US, 91206

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.